Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Warts 1Papilloma 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Valganciclovir 2Rituximab 2tocilizumab 1human papillomavirus vaccine, L1 type 16, 18 1Zidovudine 1Watchful Waiting 1Vincristine 1Tobacco Use Cessation Devices 1Surveys and Questionnaires 1Sugars 1Rapid Diagnostic Tests 1Prednisone 1Observation 1Methotrexate 1Maltose 1Light Coagulation 1Leucovorin 1Laser Therapy 1Interviews as Topic 1Interferon-alpha 1Imiquimod 1Fluorouracil 1Filgrastim 1Etoposide 1Enzyme-Linked Immunosorbent Assay 1Electrocoagulation 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Acquired Immunodeficiency Syndrome × Maltose × Clear all
NCT00454181 2011-09-16

Treatment of Oral Warts in HIV+ Patients

Ainos, Inc. (f/k/a Amarillo Biosciences Inc.

Phase 2 Completed
59 enrolled 13 charts

Acquired Immunodeficiency Syndrome, Papilloma, Warts, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡